From: Genetic variants in myostatin and its receptors promote elite athlete status
Model | Controls n (%) | All high-elite n (%) | OR | 95% CI lower | 95% CI upper | p-value adjusted |
Codominant | ||||||
GG | 158 (43.3) | 29 (56.9) | 1 | 0.20784 | ||
CG | 179 (49) | 17 (33.3) | 0.52 | 0.27 | 0.98 | |
CC | 28 (7.7) | 5 (9.8) | 0.97 | 0.35 | 2.73 | |
Dominant | ||||||
GG | 158 (43.3) | 29 (56.9) | 1 | 0.13736 | ||
CG - CC | 207 (56.7) | 22 (43.1) | 0.58 | 0.32 | 1.05 | |
Recessive | ||||||
GG - CG | 337 (92.3) | 46 (90.2) | 1 | 1 | ||
CC | 28 (7.7) | 5 (9.8) | 1.31 | 0.48 | 3.56 | |
Overdominant | ||||||
GG - CC | 186 (51) | 34 (66.7) | 1 | 0.06678 | ||
CG | 179 (49) | 17 (33.3) | 0.52 | 0.28 | 0.96 | |
Model | Controls n (%) | All elite n (%) | OR | 95% CI lower | 95% CI upper | p-value adjusted |
Codominant | ||||||
GG | 158 (43.3) | 76 (50.7) | 1 | 0.11374 | ||
CG | 179 (49) | 57 (38) | 0.66 | 0.44 | 0.99 | |
CC | 28 (7.7) | 17 (11.3) | 1.26 | 0.65 | 2.45 | |
Dominant | ||||||
GG | 158 (43.3) | 76 (50.7) | 1 | 0.2539 | ||
CG - CC | 207 (56.7) | 74 (49.3) | 0.74 | 0.51 | 1.09 | |
Recessive | ||||||
GG - CG | 337 (92.3) | 133 (88.7) | 1 | 0.38214 | ||
CC | 28 (7.7) | 17 (11.3) | 1.54 | 0.82 | 2.9 | |
Overdominant | ||||||
GG - CC | 186 (51) | 93 (62) | 1 | 0.04352 | ||
CG | 179 (49) | 57 (38) | 0.64 | 0.43 | 0.94 | |
Model | Controls n (%) | All subelite n (%) | OR | 95% CI lower | 95% CI upper | p-value adjusted |
Codominant | ||||||
GG | 158 (43.3) | 52 (40.3) | 1 | 0.39154 | ||
CG | 179 (49) | 60 (46.5) | 1.02 | 0.66 | 1.56 | |
CC | 28 (7.7) | 17 (13.2) | 1.84 | 0.94 | 3.64 | |
Dominant | ||||||
GG | 158 (43.3) | 52 (40.3) | 1 | 1 | ||
CG - CC | 207 (56.7) | 77 (59.7) | 1.13 | 0.75 | 1.7 | |
Recessive | ||||||
GG - CG | 337 (92.3) | 112 (86.8) | 1 | 0.14244 | ||
CC | 28 (7.7) | 17 (13.2) | 1.83 | 0.96 | 3.46 | |
Overdominant | ||||||
GG - CC | 186 (51) | 69 (53.5) | 1 | 1 | ||
CG | 179 (49) | 60 (46.5) | 0.9 | 0.6 | 1.35 |